Skip to content
Subscriber Only

Brexit Is Chance to Spur Biotechnology, May’s Policy Chief Says

  • U.K. to make case to retain EU medicines regulator in London
  • Business secretary touts professional services, clean energy

Brexit is an “incredible opportunity” for the U.K. to push its expertise in biotechnology and other sciences as the country is freed from burdensome European Union regulation, according to George Freeman, the chairman of Prime Minister Theresa May’s policy board.

QuickTake Brexit